Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Sino Biopharmaceutical (SBMFF) had Operating Cash Flow per Share of $0.05 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$4.02B |
|
$486.83M |
|
$742.27M |
|
$3.27B |
|
$2.43B |
|
$1.58B |
|
$-850.67M |
|
$734.10M |
|
$750.55M |
|
$665.53M |
|
$665.53M |
|
$885.33M |
|
$683.52M |
|
$1.58B |
|
$1.76B |
|
18.29B |
|
18.30B |
|
$0.03 |
|
$0.03 |
|
| Balance Sheet Financials | |
$3.43B |
|
$1.21B |
|
$5.66B |
|
$9.10B |
|
$2.72B |
|
$277.75M |
|
$428.08M |
|
$3.15B |
|
$5.95B |
|
$5.52B |
|
$5.95B |
|
18.79B |
|
| Cash Flow Statement Financials | |
$920.16M |
|
$-237.74M |
|
$-878.43M |
|
$1.04B |
|
$866.80M |
|
$-177.15M |
|
-- |
|
$-308.09M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
0.04 |
|
0.22 |
|
81.51% |
|
39.47% |
|
39.47% |
|
43.75% |
|
18.28% |
|
12.12% |
|
$796.47M |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
2.25 |
|
5.81 |
|
62.81 |
|
11.19% |
|
12.05% |
|
7.31% |
|
10.69% |
|
$0.32 |
|
$0.04 |
|
|
Operating Cash Flow per Share |
$0.05 |